The report provides a detailed analysis essential for establishing a Zafirlukast production plant. It encompasses all critical aspects necessary for Zafirlukast production, including the cost of Zafirlukast production, Zafirlukast plant cost, Zafirlukast production costs, and the overall Zafirlukast production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Zafirlukast production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Zafirlukast is a medicine that helps people with asthma breathe better. It works by blocking certain natural chemicals in the body called leukotrienes, which cause the airways in the lungs to become swollen and tight, making it hard to breathe. It reduces swelling by stopping these chemicals and keeps the airways open, helping to prevent asthma symptoms like wheezing and shortness of breath. It is taken as a pill twice a day and is used regularly to keep asthma under control. It is aimed for long-term use and should be taken even when you feel well. It also helps with some allergy symptoms like sneezing and a runny nose that can trigger asthma. It is safe but can cause mild side effects like headache or stomach upset.
The market for Zafirlukast is driven by rising global cases of asthma and allergic respiratory conditions. The increased awareness about asthma management, growing healthcare expenditure, and the demand for effective and safe treatments contribute to its market growth. The availability of generic versions expands its market access by making treatments more affordable. The Asia-Pacific region has the fastest-growing Zafirlukast market because of rising asthma cases and increasing healthcare infrastructure.
The North American and European regions have mature markets supported by higher healthcare standards and large patient populations. The industrial Zafirlukast procurement is influenced by regulations and strict quality standards imposed by agencies like the FDA and EMA. Also, sustainable production practices and technological advances, such as AI-driven process optimisation, further affect its sourcing strategies.
Raw Material for Zafirlukast Production
According to the Zafirlukast production plant project report, the key raw materials used in the production of Zafirlukast include (5 Nitroindole or 2 Bromo N, N Dimethyl 4 Nitroaniline)- (3 Methoxy 4 Methylbenzoic Acid)-Dimethyl Sulfate.
Production Process of Zafirlukast
The extensive Zafirlukast production cost report consists of the following major industrial production process:
- From 5 Nitroindole or 2 Bromo N, N Dimethyl 4 Nitroaniline: The production process of Zafirlukast involves several steps. The synthesis starts from 5-nitroindole (or alternatively from 2-bromo-N, N-dimethyl-4-nitroaniline), which is converted into the indole framework and coupled with a 3-methoxy-4-methylbenzoic acid derivative to form the indolyl methyl benzoate. The nitro group in the intermediate is then reduced to an aniline using catalytic hydrogenation with hydrogen and palladium on carbon or Raney nickel. The resulting aniline undergoes carbamoylation with cyclopentyl chloroformate in the presence of a base to form the cyclopentyl carbamate derivative. The benzoate ester group is then hydrolysed under basic conditions to produce the corresponding benzoic acid. This acid is further coupled with o-toluenesulfonamide (2-methylbenzenesulfonamide) to yield the final Zafirlukast. The crude product is purified and crystallised to get high-purity Zafirlukast as the final product.
Zafirlukast is a white to pale yellow amorphous powder with the molecular formula C31H33N3O6S and a molecular weight of 575.7 g/mol. It has a melting point around 139 degree Celsius and a density of about 1.32 g/cm³. It is almost insoluble in water but is slightly soluble in methanol and freely soluble in solvents like tetrahydrofuran, dimethyl sulfoxide (DMSO), and acetone. It has a complex structure with an indole moiety, a methoxybenzoate group, and a sulfonamide amide linkage. It is stable when stored at room temperature and should be protected from moisture to maintain potency. These physical and chemical properties affect its formulation, handling, and pharmaceutical applications for asthma management.